Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
about
External beam radiotherapy for unresectable hepatocellular carcinomaMultimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular CarcinomaMultimodal treatment of hepatocellular carcinoma on cirrhosis: an updateHepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma MeetingManagement of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016The future of nanosized radiation enhancersTranshepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial.Radiobiological effect induced by different activities of (125)I seed brachytherapy in a hepatocellular carcinoma model.Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicityDihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells.Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patientsGated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements.Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.External beam radiotherapy for unresectable hepatocellular carcinoma.Charged particles for liver cancer.Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumorsA feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images.Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.A dose-volume intercomparison of volumetric-modulated arc therapy, 3D static conformal, and rotational conformal techniques for portal vein tumor thrombus in hepatocellular carcinomaGanetespib radiosensitization for liver cancer therapyClinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma.Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.Nonsurgical treatment for localized hepatocellular carcinoma.Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients.Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapyLong-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.Radiation oncology: physics advances that minimize morbidity.Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma.Pattern of distant extrahepatic metastases in primary liver cancer: a SEER based studyStereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.Clinical implications for imaging of vascular invasion in hepatocellular carcinoma.Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.Dose to organ at risk and dose prescription in liver SBRT.Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer.Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two casesPrognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14-17)Clinical research on alternating hyperfraction radiotherapy for massive hepatocellular carcinoma.
P2860
Q24194024-1E3380BB-E860-4897-997B-FA9EB2829C93Q26797643-C2DC3CAA-C6A6-431A-BA67-DB12A3730EB6Q26825172-9194A5F3-C9C9-4E92-B3CC-913005811070Q26828407-AD56B939-91B3-453E-97A7-1D0F2C676107Q28072595-E61D587C-1E4F-46D3-A3A1-B36DF442470AQ28080799-CD0795DA-7427-4072-85FE-7A5626674F19Q33660203-E20A4014-72EC-4598-A031-3148139014DCQ35017131-910E1D3B-CC79-4BF5-9F80-CF5C924A02DEQ35023155-3AB7D675-3316-4DA8-8466-1754BE3A5A59Q35620926-6E1CAAB4-5D70-43A9-A90D-BC91B4820855Q36104455-F379A2D4-221D-4303-8159-0B9B92BD1D9AQ36201159-EE075CF3-7DA9-4233-80DF-C927D0428834Q36275798-457BE85D-7EDE-453B-B734-B91A59BAE0C8Q36299237-2CA5E7AB-BD13-4F46-91FD-73E6C9BADCFBQ36430664-145BF141-1A21-49EA-9B5E-DFF4D59D272EQ36570322-27DBCAA6-F778-4B5E-9FF2-81C32DB01DA1Q36798881-DF5F6573-FFAA-455B-8FF0-90D68D7B5FEEQ36914411-92DF855F-4627-48CD-BCA6-9E06560A7C8AQ36936990-4DDCECBF-0ADE-46EE-B3CB-28856A627B35Q37006939-56701178-CCC3-4311-85C1-7B1363F6FE90Q37013260-7CC86B1E-A905-4EBD-BA43-9A8C92DEC2CDQ37059598-6F9D09EA-5E06-4589-B2E1-DA845C149A50Q37524976-D17EB3B7-2004-4897-B1D2-C7C224A4D2F7Q37578521-64460879-8EB9-47E1-B8F1-41119DA6175BQ37600883-22D5A0CF-C3EB-49C2-A1BF-05E5EB7862A8Q37613015-D91A38B8-3380-4E30-8AD1-5F0B737DD3E4Q37714373-B7BC5555-3490-4707-AE1E-A2E82F60C5CAQ37735607-25A439A3-7E0C-445E-A0D2-4A7ECF43709EQ38282463-9B653DFD-AB41-427D-A55A-6C7A5753FE1FQ38294588-0C3F28C1-EDEE-4443-9477-F9A437F63950Q38440327-F9190E62-C0FE-4EFC-B333-7A0736C36006Q38640503-3B3594E6-908E-45E4-AAA5-F88D3458C10CQ38677020-65C23169-B594-4A6B-8974-07BFD1DBDE0DQ38824638-C59F8877-8B0B-4402-9AE9-0B7C71AB5AC1Q39043108-B32660EA-BD37-4F3E-88D2-B09F192D1A5EQ39296799-F3F9F1EB-F834-4E27-9284-C34BC56098AFQ40896876-C3ADE95A-DC2A-4501-8700-83027B15DB43Q41072005-530C3869-4181-498C-9C83-97BA71B3A068Q41083736-442D40D2-05FA-40CC-8665-6B30FE89A3F5Q41552720-CE32D086-AC3B-4A1E-ADD0-9634EA314B7D
P2860
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@ast
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@en
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@nl
type
label
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@ast
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@en
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@nl
prefLabel
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@ast
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@en
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@nl
P1476
Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
@en
P356
10.1016/J.IJROBP.2012.08.043
P407
P577
2012-12-06T00:00:00Z